Sterile Compounding Pharmacies Market Industry Outlook, Opportunities in Market And Expansion By 2033

The Sterile Compounding Pharmacies Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Sterile Compounding Pharmacies Market:
https://www.thebusinessresearchcompany.com/report/sterile-compounding-pharmacies-global-market-report

According to The Business Research Company’s Sterile Compounding Pharmacies Global Market Report 2024, The sterile compounding pharmacies market size has grown strongly in recent years. It will grow from $4.99 billion in 2023 to $5.3 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%.  The  growth in the historic period can be attributed to patient safety concerns, shift towards personalized medicine, home infusion therapies, clinical trials and investigational drugs, support for rare diseases..

The sterile compounding pharmacies market size is expected to see strong growth in the next few years. It will grow to $6.7 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%.  The growth in the forecast period can be attributed to rise in chronic diseases, aging population and healthcare needs, drug shortages and supply chain disruptions, advancements in precision medicine, increased focus on patient-centric care.. Major trends in the forecast period include automation and robotics integration, stringent regulatory compliance, personalized medicine and specialized compounds, shift to outsourced compounding services, technological advances in aseptic techniques..

Increasing demand for personalized medicine is expected to propel the growth of the sterile compounding pharmacies market going forward. Personalized medicine is a type of medicine that prevents, diagnoses, or treats disease by using information about a person’s genes or proteins. Sterile compounding pharmacies play a significant role in offering personalized medications to patients in a sterile environment to provide customized medication to people based on their needs and avoid the possibility of intolerance to certain doses or drug compounds. This improves treatment results and increase patient satisfaction and adherence to therapy. For instance, in 2022, according to the report published by Personalized Medicine Coalition, a US-based company operating in personalized medicine services, personalized medicines have now accounted for at least a quarter of new medication approvals, with the approval of 12 new personalized medicines in 2022 which has increased dramatically. Therefore, the increasing demand for personalized medicine is driving the sterile compounding pharmacies market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12073&type=smp

The sterile compounding pharmacies market covered in this report is segmented –

1) By Product: Injectables, Nasal, Ocular, Otic
2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas
3) By Route of Administrations: Intravenous, Intramuscular, Subcutaneous
4) By End-Users: Adults, Pediatrics, Geriatrics, Veterinary

The adoption of robotic automation is a key trend gaining popularity in the sterile compounding pharmacies market. Major companies operating in the sterile compounding pharmacies market are focused on robotic automation to strengthen their position in the market. For instance, in March 2023, Omnicell Inc., a US-based healthcare technology company, introduced IVX Station, a robotic compounding technology for safe and efficient sterile compounding preparations using automation. The IVX Station features an automated compounding process in an ISO Class 5 environment, as well as temperature, humidity, and particle monitoring continually. It was also designed with safety in mind, with advanced vision systems, gravimetric verification, auto-labeling, and automated application of tamper-evident syringe caps. Furthermore, this new technology allows for scalability with a cloud-based formulation library, which is constantly updated to guarantee manufacturers access to the most recent authorized formulations.

The sterile compounding pharmacies market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model